Piramal -Cefepime for Injection, USP
Piramal`s Cefepime for Injection, USP is available through the wholesaler or distributor of your choice.
PRODUCT NAME AND COMPOSITION: Cefepime for Injection, an injectable antibacterial solution. Supplied in land 2 grams vials.
Please refer to Full Prescribing Information (FPI) before prescribing.
IN DICATIONS: Treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed in the FPL
DOSAGE AND ADMINISTRATION: See FPI for full details. Cefepime for injection may be administered by either IV or IM routes. For intravenous administration, the dose can be given by slow intravenous injection over 30 minutes. The recommended adult dosage of Cefepime for injection is 1 to 2 grams every 8 to 12 hours for treatment duration of 7 to 10 days. Pediatric Patients (2 months to 16 years): The recommended daily dose is 50 mg per kg of body weight administered via intravenous infusion in equally divided doses every 8 to 12 hours. Pediatric patients weighing 40 kg or more should be dosed according to adult recommendations. Patients with Impaired Renal Function: The dose of Cefepime for injection in such patients should be adjusted to compensate for the slower rate of renal elimination, in accordance with the guidelines contained in the FPI. The same guidelines must be specifically followed for patients undergoing Hemodialysis and Continuous Ambulatory Peritoneal Dialysis (CAPD).
CONTRAINDICATIONS: Cefepime for injection is contraindicated in patients who have shown immediate hypersensitivity reactions to Cefepime or the cephalosporin class of antibiotics, penicillins or other beta-lactam antibiotics.
COMMON SIDE EFFECTS: Local: Pain at IM injection site, pain at IV injection site (3%), phlebitis (1.3%). Systemic: Rash (4%), diarrhea (3%), nausea (2%), vomiting (1%), pruritus (1%), fever (1%), and headache (1%).